Triple negative breast cancer (TNBC) is a subtype of breast cancer characterized by
absence of estrogen (ER) receptor, progesterone (PR) receptor, and human epidermal …

Triple negative breast cancer (TNBC) is one of the most aggressive types of breast cancer.
Owing to the absenteeism of hormonal receptors expressed at the cancerous breast cells …

Breast cancer is a challenging health issue in women and the second-leading cause of
mortality around world. In this review, we addressed beneficial role of siRNA to control …

A major problem in cancer treatment is the multidrug resistance. siRNA inhibitors have great
advantages to solve the problem, if the bottleneck of their delivery could be well addressed …

Breast cancer (BC) is among the most frequent malignancies women face around the globe.
Nanotherapeutics are constantly evolving to overcome the limitations of conventional …

RNA interference (RNAi) has increased the possibility of restoring RNA drug targets for
cancer treatment. Small interfering RNA (siRNA) is a promising therapeutic RNAi tool that …

Chemotherapeutic agents have certain limitations when it comes to treating cancer, the most
important being severe side effects along with multidrug resistance developed against them …

Breast cancer is one of the most common types of cancer among women globally. It is
caused by mutations in the estrogen/progesterone receptors and conventional treatment …

RNAi is a remarkable treatment strategy to knock down gene overexpression in a variety of
disorders, including cancers. RNAi processes allow siRNAs to detect and degrade a …

The development of an efficient small interfering RNA (siRNA) delivery system has held
scientists interest since the discovery of the RNA interference mechanism (RNAi). This …